Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people

BACKGROUND: Concerns have been raised that angiotensin-converting enzyme-inhibitors (ACE-I) and angiotensin receptor blockers (ARBs) might facilitate transmission of severe acute respiratory syndrome coronavirus 2 leading to more severe coronavirus disease (COVID-19) disease and an increased risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dambha-Miller, Hajira, Hinton, William, Wilcox, Christopher R, Lemanska, Agnieszka, Joy, Mark, Feher, Michael, Stuart, Beth, de Lusignan, Simon, Hippisley-Cox, Julia, Griffin, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452130/
https://www.ncbi.nlm.nih.gov/pubmed/36003039
http://dx.doi.org/10.1093/fampra/cmac094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452130/
https://www.ncbi.nlm.nih.gov/pubmed/36003039
http://dx.doi.org/10.1093/fampra/cmac094

Ejemplares similares